Bowel disorders

American Journal of Gastroenterology

Volumn 105, Issue 4, 2010, Pages 775-785

  Spiller, Robin C ^a   Thompson, W Grant ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISPAGULA; MACROGOL; ORAL CONTRACEPTIVE AGENT; SUMATRIPTAN;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; BLOATING; CASE REPORT; CHRONIC DIARRHEA; CONSTIPATION; DEFECATION HABIT; DIAGNOSTIC VALUE; DIARRHEA; DIETARY FIBER; FECES ANALYSIS; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INTESTINE FUNCTION; IRRITABLE COLON; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOM;

ABDOMINAL PAIN; ADULT; ALGORITHMS; CHRONIC DISEASE; COLONIC DISEASES, FUNCTIONAL; CONSTIPATION; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; FEMALE; HUMANS; MALE; QUESTIONNAIRES; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 77950476283     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.69     Document Type: Review

References (61)

1. Costanza CD, Longstreth GF, Liu AL. Chronic abdominal wall pain: clinical features, health care costs, and long-term outcome. Clin Gastroenterol Hepatol 2004; 2: 395-399
2. Gregory PL, Biswas AC, Batt ME. Musculoskeletal problems of the chest wall in athletes. Sports Med 2002; 32: 235-250
3. Hahn B, Watson M, Yan S et al. Irritable bowel syndrome symptom patterns: frequency, duration, and severity. Dig Dis Sci 1998; 43: 2715-2718
4. Ford AC, Talley NJ, Veldhuyzen Van Zanten SJ et al. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA 2008; 300: 1793-1805
5. Connell AM, Hilton C, Irvine G et al. Variation of bowel habit in two population samples. Br Med J 1965; 2: 1095-1099
6. Heaton KW, O ' Donnell LJ. An offi ce guide to whole-gut transit time. Patients ' recollection of their stool form. J Clin Gastroenterol 1994; 19: 28-30.
7. Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491
8. Probert CS, Emmett PM, Cripps HA et al. Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome. Gut 1994; 35: 1455-1458
9. Accarino A, Perez F, Azpiroz F et al. Abdominal distention results from caudo-ventral redistribution of contents. Gastroenterology 2009; 136: 1544-1551
10. Houghton LA, Lea R, Agrawal A et al. Relationship of abdominal bloating to distention in irritable bowel syndrome and eff ect of bowel habit. Gastroenterology 2006; 131: 1003-1010
11. Agrawal A, Houghton LA, Lea R et al. Bloating and distention in irritable bowel syndrome: the role of visceral sensation. Gastroenterology 2008; 134: 1882-1889
12. Sykes MA, Blanchard EB, Lackner J et al. Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Behav Med 2003; 26: 361-372
13. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370
14. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-266
15. North CS, Downs D, Clouse RE et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2004; 2: 787-795
16. Levy RL, Olden KW, Naliboff BD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1447-1458
17. Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients ' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998; 10: 415-421
18. Brandt LJ, Chey WD, Foxx-Orenstein AE et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 (Suppl 1): S1-35.
19. Spiller R, Aziz Q, Creed F et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 1770-1798
20. Kruis W, Th ieme C, Weinzierl M et al. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984; 87: 1-7.
21. Vanner SJ, Depew WT, Paterson WG et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999; 94: 2912-2917
22. Sloth H, Jorgensen LS. Chronic non-organic upper abdominal pain: diagnostic safety and prognosis of gastrointestinal and non-intestinal symptoms. A 5-to 7-year follow-up study. Scand J Gastroenterol 1988; 23: 1275-1280
23. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97: 2812-2819
24. Goka AK, Rolston DD, Mathan VI et al. The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis. Trans R Soc Trop Med Hyg 1990; 84: 66-67
25. Weitzel T, Dittrich S, Mohl I et al. Evaluation of seven commercial antigen detection tests for Giardia and Cryptosporidium in stool samples. Clin Microbiol Infect 2006; 12: 656-659
26. Nagaty IM, Hegazi MM. Dot-ELISA copro-antigen and direct stool examination in diagnosis of giardiasis patients. J Egypt Soc Parasitol 2007; 37: 641-648
27. Hamm LR, Sorrells SC, Harding JP et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfi lling the Rome Criteria. Am J Gastroenterol 1999; 94: 1279-1282
28. Pardi DS, Loft us EV Jr, Smyrk TC et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007; 56: 504-508
29. Solem CA, Loft us EV Jr, Fletcher JG et al. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008; 68: 255-266
30. Posserud I, Stotzer PO, Bjornsson ES et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802-808
31. Berthold HK, Schober P, Scheurlen C et al. Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test. J Gastroenterol 2009; 44: 944-951
32. Williams AJK, Merrick MV, Eastwood MA. Idiopathic bile acid malabsorption \a review of clinical presentation, diagnosis, and response to treatment. Gut 1991; 32: 1004-1006
33. Sinha L, Liston R, Testa HJ et al. Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to cholestyramine. Aliment Pharmacol Ther 1998; 12: 839-844
34. Cabrera-Abreu JC, Davies P, Matek Z et al. Performance of blood tests in diagnosis of infl ammatory bowel disease in a specialist clinic. Arch Dis Child 2004; 89: 69-71.
35. Tibble JA, Sigthorsson G, Foster R et al. Use of surrogate markers of infl ammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002; 123: 450-460
36. Sanders DS, Carter MJ, Hurlstone DP et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfi lling ROME II criteria referred to secondary care. Lancet 2001; 358: 1504-1508
37. Whitehead WE, Crowell MD, Bosmajian L et al. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples. Gastroenterology 1990; 98: 336-340
38. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-1988
39. Simoons FJ. The geographic hypothesis and lactose malabsorption a weighing of the evidence. Dig Dis Sci 1978; 23: 963-979
40. Tolliver BA, Jackson MS, Jackson KL et al. Does lactose maldigestion really play a role in the irritable bowel? J Clin Gastroenterol 1996; 23: 15-17
41. Suarez FL, Savaiano DA, Levitt MD. A comparison of symptoms aft er the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995; 333: 1-4.
42. Shepherd SJ, Parker FC, Muir JG et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6: 765-771
43. Atkinson W, Sheldon TA, Shaath N et al. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004; 53: 1459-1464
44. Nanda R, James R, Smith H et al. Food intolerance and the irritable bowel syndrome. Gut 1989; 30: 1099-1104
45. Heaton KW, Ghosh S, Braddon FE. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study wiThemphasis on stool form. Gut 1991; 32: 73-79
46. Tillisch K, Labus JS, Naliboff BD et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005; 100: 896-904. (Pubitemid 40592385)
47. Drossman DA, Morris CB, Hu YM et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defi ning an alternator. Gastroenterology 2005; 128: 580-589
48. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for eff ective dietary management. J Am Diet Assoc 2006; 106: 1631-1639
49. Afzalpurkar RG, Schiller LR, Little KH et al. The self-limited nature of chronic idiopathic diarrhea. N Engl J Med 1992; 327: 1849-1852
50. Parker TJ, Naylor SJ, Riordan AM et al. Management of patients with food intolerance in irritable bowel syndrome: The development and use of an exclusion diet. J Hum Nutrit Diet 1995; 8: 159-166
51. Lavo B, Stenstam M, Nielsen AL. Loperamide in treatment of irritable bowel syndrome \a double-blind placebo controlled study. Scand J Gastroenterol Suppl 1987; 22: 77-80.
52. Read NW, Krejs GJ, Read MG et al. Chronic diarrhea of unknown origin. Gastroenterology 1980; 78: 264-271
53. Jemal A, Siegel R, Ward E et al. Cancer statistics. CA Cancer J Clin 2007; 57: 43-66.
54. da Silva JG, De Brito T, Cintra Damiao AO et al. Histologic study of colonic mucosa in patients with chronic diarrhea and normal colonoscopic fi ndings. J Clin Gastroenterol 2006; 40: 44-48
55. Al-Sultan AI, Larbi EB, Magbool G et al. Clinical presentation of spontaneous primary hypothyroidism in adults. Ann Saudi Med 1995; 15: 143-147
56. Lamy O, Jenzer-Closuit A, Burckhardt P. Hypercalcaemia of malignancy: an undiagnosed and undertreated disease. J Intern Med 2001; 250: 73-79
57. Th omas J, Karver S, Cooney GA et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358: 2332-2343
58. Bannister JJ, Davison P, Timms JM et al. Eff ect of stool size and consistency on defecation. Gut 1987; 28: 1246-1250
59. DiPalma JA, Cleveland MV, McGowan J et al. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol 2007; 102: 1436-1441 (Pubitemid 46976282)
60. Passmore AP, Wilson-Davies K, Stoker C et al. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fi bre combination. BMJ 1993; 307: 769-71.
61. Simoons FJ. The geographic hypothesis and lactose malabsorption a weighing of the evidence. Dig Dis Sci 1978; 23: 963-979